The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Sell(S) | 100 | $47.83 | $5K |
| Sep 1, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Sell(S) | 5K | $47.20 | $214K |
| Sep 1, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Sell(S) | 1K | $45.86 | $60K |
| Sep 1, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Conversion(C) | 6K | — | $0 |
| Sep 1, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 18K | — | $0 |
| Sep 1, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Conversion(C) | 18K | — | $0 |
| Sep 1, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 18K | $0.34 | $6K |
| Aug 18, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Sell(S) | 400 | $55.05 | $22K |
| Aug 18, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Sell(S) | 519 | $54.20 | $28K |
| Aug 18, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Sell(S) | 3K | $53.13 | $160K |
| Aug 18, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Conversion(C) | 4K | — | $0 |
| Aug 18, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 12K | — | $0 |
| Aug 18, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Conversion(C) | 12K | — | $0 |
| Aug 18, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 12K | $0.34 | $4K |
| Aug 6, 2026 | Berrios John Joseph | Chief Commercial Officer | Grant(A) | 141K | — | $0 |
| Aug 6, 2026 | Berrios John Joseph | Chief Commercial Officer | Grant(A) | 175K | — | $0 |
| Aug 4, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 12K | $0.34 | $4K |
| Aug 4, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Conversion(C) | 12K | — | $0 |
| Aug 4, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 12K | — | $0 |
| Aug 4, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Conversion(C) | 4K | — | $0 |
| Aug 4, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Sell(S) | 3K | $49.29 | $153K |
| Aug 4, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Sell(S) | 839 | $50.03 | $42K |
| Jul 22, 2026 | FMR LLC | 10% Owner | Sell(S) | 1K | $50.07 | $68K |
| Jul 22, 2026 | FMR LLC | 10% Owner | Sell(S) | 16K | $50.07 | $805K |
| Jul 14, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 24K | $0.34 | $8K |
| Jul 14, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Conversion(C) | 24K | — | $0 |
| Jul 14, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 24K | — | $0 |
| Jul 14, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Conversion(C) | 8K | — | $0 |
| Jul 14, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Sell(S) | 6K | $50.80 | $319K |
| Jul 14, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Sell(S) | 2K | $51.71 | $83K |
| Jun 25, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 24K | $0.34 | $8K |
| Jun 25, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Conversion(C) | 24K | — | $0 |
| Jun 25, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Option exercise(M) | 24K | — | $0 |
| Jun 25, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Conversion(C) | 8K | — | $0 |
| Jun 25, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Sell(S) | 8K | $49.08 | $387K |
| Jun 17, 2026 | Russell Angus C. | Director | Grant(A) | 39K | — | $0 |
| Jun 17, 2026 | Love Ted W | Director | Grant(A) | 39K | — | $0 |
| Jun 17, 2026 | Waldstreicher Joanne | Director | Grant(A) | 39K | — | $0 |
| Jun 17, 2026 | Dobmeier Eric | Director | Grant(A) | 39K | — | $0 |
| Jun 17, 2026 | Tetlow Sharon | Director | Grant(A) | 39K | — | $0 |
| Jun 17, 2026 | Welch Daniel G | Director | Grant(A) | 39K | — | $0 |
| Apr 15, 2026 | Lang Matthew | COO & GC | Grant(A) | 185K | — | $0 |
| Apr 15, 2026 | Lang Matthew | COO & GC | Grant(A) | 224K | — | $0 |
| Apr 14, 2026 | FMR LLC | 10% Owner | Sell(S) | 1K | $55.07 | $75K |
| Apr 14, 2026 | FMR LLC | 10% Owner | Sell(S) | 16K | $55.07 | $886K |
| Mar 19, 2026 | Stevens Raymond C | CHIEF EXECUTIVE OFFICER, Director | Grant(A) | 260K | — | $0 |
| Mar 19, 2026 | Stevens Raymond C | CHIEF EXECUTIVE OFFICER, Director | Grant(A) | 322K | — | $0 |
| Mar 19, 2026 | Hall Ashley | Chief Development Officer | Grant(A) | 48K | — | $0 |
| Mar 19, 2026 | Hall Ashley | Chief Development Officer | Grant(A) | 59K | — | $0 |
| Mar 19, 2026 | Yoon Jun | CHIEF FINANCIAL OFFICER | Grant(A) | 104K | — | $0 |
| Mar 19, 2026 | Yoon Jun | CHIEF FINANCIAL OFFICER | Grant(A) | 129K | — | $0 |
| Mar 19, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Grant(A) | 43K | — | $0 |
| Mar 19, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Grant(A) | 54K | — | $0 |
| Mar 19, 2026 | Ma Yingli | CHIEF TECHNOLOGY OFFICER | Grant(A) | 33K | — | $0 |
| Mar 19, 2026 | Ma Yingli | CHIEF TECHNOLOGY OFFICER | Grant(A) | 40K | — | $0 |
| Mar 19, 2026 | Coll Crespo Blas | CHIEF MEDICAL OFFICER | Grant(A) | 76K | — | $0 |
| Mar 19, 2026 | Coll Crespo Blas | CHIEF MEDICAL OFFICER | Grant(A) | 94K | — | $0 |
| Mar 3, 2026 | Stevens Raymond C | CHIEF EXECUTIVE OFFICER, Director | Tax withholding(F) | 53K | $20.99 | $1.1M |
| Mar 3, 2026 | Hall Ashley | Chief Development Officer | Tax withholding(F) | 5K | $20.99 | $102K |
| Mar 3, 2026 | Yoon Jun | CHIEF FINANCIAL OFFICER | Tax withholding(F) | 22K | $20.99 | $468K |
| Mar 3, 2026 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Tax withholding(F) | 19K | $20.99 | $393K |
| Mar 3, 2026 | Ma Yingli | CHIEF TECHNOLOGY OFFICER | Tax withholding(F) | 11K | $20.99 | $237K |
| Mar 3, 2026 | Coll Crespo Blas | CHIEF MEDICAL OFFICER | Tax withholding(F) | 12K | $20.99 | $248K |
| Jan 15, 2026 | FMR LLC | 10% Owner | Sell(S) | 6K | $84.22 | $547K |
| Jan 15, 2026 | FMR LLC | 10% Owner | Sell(S) | 230 | $85.04 | $20K |
| Jan 15, 2026 | FMR LLC | 10% Owner | Sell(S) | 4K | $83.35 | $323K |
| Jan 15, 2026 | FMR LLC | 10% Owner | Sell(S) | 5K | $82.10 | $450K |
| Jan 15, 2026 | FMR LLC | 10% Owner | Sell(S) | 20 | $85.04 | $2K |
| Jan 15, 2026 | FMR LLC | 10% Owner | Sell(S) | 330 | $83.35 | $28K |
| Jan 15, 2026 | FMR LLC | 10% Owner | Sell(S) | 465 | $82.10 | $38K |
| Jan 15, 2026 | FMR LLC | 10% Owner | Sell(S) | 552 | $84.22 | $46K |
| Dec 8, 2025 | FMR LLC | 10% Owner | Sell(S) | 475 | $94.61 | $45K |
| Dec 8, 2025 | FMR LLC | 10% Owner | Sell(S) | 16K | $61.45 | $955K |
| Dec 8, 2025 | FMR LLC | 10% Owner | Sell(S) | 1K | $61.45 | $81K |
| Dec 8, 2025 | FMR LLC | 10% Owner | Sell(S) | 8K | $92.52 | $771K |
| Dec 8, 2025 | FMR LLC | 10% Owner | Sell(S) | 2K | $94.00 | $203K |
| Dec 8, 2025 | FMR LLC | 10% Owner | Sell(S) | 6K | $94.61 | $529K |
| Dec 8, 2025 | FMR LLC | 10% Owner | Sell(S) | 17K | $61.05 | $1.0M |
| Dec 8, 2025 | FMR LLC | 10% Owner | Sell(S) | 183 | $94.00 | $17K |
| Dec 8, 2025 | FMR LLC | 10% Owner | Sell(S) | 709 | $92.52 | $66K |
| Dec 8, 2025 | FMR LLC | 10% Owner | Sell(S) | 1K | $61.05 | $86K |
| Nov 20, 2025 | Stevens Raymond C | CHIEF EXECUTIVE OFFICER, Director | Grant(A) | 824 | — | $0 |
| Nov 20, 2025 | Hall Ashley | Chief Development Officer | Grant(A) | 237 | — | $0 |
| Sep 18, 2025 | Hall Ashley | Chief Development Officer | Tax withholding(F) | 6K | $7.74 | $47K |
| Sep 18, 2025 | Coll Crespo Blas | CHIEF MEDICAL OFFICER | Tax withholding(F) | 8K | $7.74 | $63K |
| Jul 30, 2025 | FMR LLC | 10% Owner | Sell(S) | 26K | $17.87 | $470K |
| Jul 1, 2025 | Stevens Raymond C | CHIEF EXECUTIVE OFFICER, Director | Tax withholding(F) | 16K | $6.84 | $110K |
| Jul 1, 2025 | Stevens Raymond C | CHIEF EXECUTIVE OFFICER, Director | Grant(A) | 90K | — | $0 |
| Jul 1, 2025 | Yoon Jun | CHIEF FINANCIAL OFFICER | Grant(A) | 40K | — | $0 |
| Jul 1, 2025 | Yoon Jun | CHIEF FINANCIAL OFFICER | Tax withholding(F) | 7K | $6.84 | $48K |
| Jul 1, 2025 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Grant(A) | 57K | — | $0 |
| Jul 1, 2025 | Ma Yingli | CHIEF TECHNOLOGY OFFICER | Grant(A) | 24K | — | $0 |
| Jul 1, 2025 | Coll Crespo Blas | CHIEF MEDICAL OFFICER | Grant(A) | 8K | — | $0 |
| Jul 1, 2025 | Coll Crespo Blas | CHIEF MEDICAL OFFICER | Tax withholding(F) | 1K | $6.84 | $10K |
| Jul 1, 2025 | Lin Xichen | CHIEF SCIENTIFIC OFFICER | Tax withholding(F) | 13K | $6.84 | $88K |
| Jul 1, 2025 | Ma Yingli | CHIEF TECHNOLOGY OFFICER | Tax withholding(F) | 4K | $6.84 | $31K |
| Jun 23, 2025 | Welch Daniel G | Director | Grant(A) | 52K | — | $0 |
| Jun 23, 2025 | Tetlow Sharon | Director | Grant(A) | 52K | — | $0 |
| Jun 23, 2025 | Dobmeier Eric | Director | Grant(A) | 52K | — | $0 |
| Jun 23, 2025 | Waldstreicher Joanne | Director | Grant(A) | 52K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-03. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for GPCR